https://clinicaltrials.gov/ct2/show/NCT02975336?type=Intr&cond=Lupus&phase=012345&lupd_s=03%2F05%2F2019&lupd_d=14
Condition : Systemic Lupus Erythematosus
Interventions : Drug: Placebo; Drug: M2951
Sponsors : EMD Serono Research & Development Institute, Inc.; Merck KGaA, Darmstadt, Germany
Recruiting
A Phase II Study of M2951 in Systemic Lupus Erythematosus (SLE)
NCT02975336
Tue, 29 Nov 2016 12:00:00 EST